. Trypsin activates, and is co-expressed with matrix metalloproteases (MMPs), which are known to facilitate invasion and metastasis (Nyberg et al., 2002; . Polymorphonuclear leukocyte elastase (referred to as elastase) disintegrates matrix proteins (Barrett, 1981) , implicating this enzyme in cancer cell invasion and metastasis. Increased levels of elastase have been shown to be strongly associated with recurrence and death in breast cancer patients (Foekens et al., 2003) suggesting that elastase could have a role in tumor progression leading to metastasis in breast cancer (Queen, 2005; Akizuki et al., 2007; Mittendorf, 2012) . Thus one possibility of cancer treatment is to suppress the activity of proteases (SPs and MMPs) that play an important role in tumour invasion and metastasis (Jedina and Maliar, 2005; Hunt et al., 2013) . Therefore, proteases present a promising strategy for anticancer and antimetastatic therapy. Protease inhibitors being found to be as special agents in anticancer therapy, have been isolated from plants (Khan et al., 2008; Tochi et al., 2008) or bacteria (Hossain et al., 2007) as their natural source. Its main feature includes their ability to form strong protease-PI complex, inhibiting the protelytic activity. PIs are mostly isolated from plants suggesting plant PIs may open a new anticancer strategy in future. In this communication we have tried to explore the anticancer activity of potease inhibitors isolated from Lavatera cashmeriana seeds. Lavatera cashmeriana is a medicinal plant widely used in traditional folk medicine (Kaul, 1997) . Four protease inhibitors viz LC-pi I, II, III and IV were purified from seeds of Lavatera cashmeriana. These four inhibitors inhibited trypsin, chymotrypsin and elastase in vitro (Rakashanda et al., 2013) and antibacterial activity against Klebsiella pnuemoniae and Pseudomonas aeruginosa (Rakashanda et al., 2012) . To explore the application of all LC-pis as antitumor agents, we examined their suppressive effects on various cell lines. In this article, we report on their capacity to suppress the growth of cells, such as THP-1, NCIH322, Colo205 and HCT-116
Materials and Methods

Inhibitors and chemicals
LC-pis were purified from the seeds of Lavatera cashmeriana, as described previously (Rakashanda et al., 2012) . RPMI-1640 medium (#N 3520), rhodamine-123 (Rh-123) (#R 8004), penicillin (#P 3032), streptomycin (#S 9137), fetal bovine serum (# 7524), mitomycin (#M 4287), sodium bicarbonate (#S 5761), phosphate buffer saline (PBS) (#P3831), sulphorhodamine (SRB) (#1402), trypsin (#T 4799), paclitaxel (#T 7402), 5 fluorouraci l (5-FU) (#F 6627), gentamycin sulfate (#G 1264) were procured from SigmaeAldrich. Trichloroacetic acid was purchased from Merck Specialties Private Ltd.
Cells and cell culture
Human acute monocytic leukemia cell line (THP-1) was procured from National Centre for Cell Sciences (NCCS), Pune, India. Human lung carcinoma cell line NCIH322 and human colon cancer cell lines (HCT-116 and colo-205) were obtained from National Cancer Institute, Frederick, U.S.A. All the cells that were used were grown in RPMI-1640/MEM medium containing 10% FCS, 100 unit Penicillin/100 µg Streptomycin per ml medium. Cells were allowed to grown in CO 2 incubator (Thermo Scientific USA) at 37 o C with 98% humidity and 5% CO 2 gas environment. The cells used for the assay were in logarithmic phase.
Determination of suppressive activity of protease inhibitors
The suppressive activity of inhibitors was evaluated according to the soluble SRB assay (Hoghton et al., 2007) . Briefly, required µl of a cell suspension containing required cells/ml was added to each well in a 96-well microtiter plate and was cultured in RPMI-1640 mediums previously stipulated. The cells were allowed to adhere overnight, and then media containing purified inhibitors at different concentrations were added. Originally 30, 50, 70 and 100µg/ml of all four test samples were used. Also peclitexal and 5-Fluorouracil were used as positive controls. The plates were assayed after 48hrs. The cells were fixed by adding 50µl of ice-cold 50% TCA to each well for 60min in case of adherent cells. The plates were washed five times in running tap water and stained with 100ml per well SRB reagent (0.4% w/v SRB in 1% acetic acid for 30min). The plates were washed five times in 1% acetic acid to remove unbound SRB and allowed to dry overnight. SRB was solublized with 100µl Trisbase (10mM) per well, shaken for 5min and the OD was measured at 570 nm with reference wavelength of 620nm. Further, the IC 50 values in the presence of purified inhibitors on the cancer cells of different tissue origin used for screening were determined by non-linear regression analysis using Graph Pad Software (2236 Avenida de la Playa La Jolla, CA 92037,USA).
Statistical analysis
The experiments were performed at least three times, independently. A logistic non-linear regression model was fit to the data using using Graph Pad Software to calculate the IC 50 . The data obtained were expressed as 'mean±standard deviation'. A value of p<0.05 was considered as significant.
Results
LC-pi I and II were found to significantly inhibit the in vitro growth of THP-1, NCIH322, Colo205, whereas only LC-pi I inhibited growth of HCT-116 cells but not LC-pi II in a dose dependent manner. Further LC-pi III and IV could not inhibit the growth of these cells (Table  1) . The calculated IC 50 values are given in Table 2 . IC 50 values suggest that NCIH322 lung cancer cells are strongly inhibited by both inhibitors at lower concentrations in comparison to other cell lines. Their pharmacological effects may be mediated through inhibition of the protease activity and the subsequent modulation of the protease pro-survival signaling as LC-pi I and II strongly inhibited the in vitro activity of trypsin, elastase and chymotrypsin (Clemente et al., 2010) , also TI1B, a major Bowman-Birk isoinhibitor from pea (Pisum sativum L.) on HT29 colon cancer cells (Clemente et al., 2012) and antitumor Protease Inhibitor from Mini-Black Soybean (Ye and Ng, 2011) . These evidences have made the plant protease inhibitors to be considered as neutraceutical proteins, owing to prevention and treatment of cancer (de Mejia and Dia, 2010) .
Discussion
In conclusion, LC-pi I and II may have a potential application as anticancer agents. Nevertheless, a better understanding on the detailed mechanism of how LC-pi I and II exert its suppressive activity would be valuable, thus warrants further investigations.
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